第128回HGPIセミナー「乳がん診療からみる、医療格差の捉え方」

毎年10月は乳がん啓発を目的としたピンクリボン月間とされています。この時期は、日本ではもちろんのこと、世界各国で乳がん対策に関する啓発やイベントが行われています。

日本医療政策機構（HGPI）でも、乳がん対策の一環として、乳がん診療からみた医療上の格差について様々な側面から課題について理解を深めることを目的としてHGPIセミナーを開催いたします。本セミナーでは、福島県立医科大学 医学部 腫瘍内科学講座 主任教授の佐治 重衡 氏をお招きし、乳がん診療における現在と、あるべき医療提供体制についてお話いただきます。医療界全体として課題と認識されている格差の課題について、乳がん診療の視点からひも解いてみたいと思います。


■ 登壇者プロフィール

佐治 重衡 氏（公立大学法人 福島県立医科大学 医学部 腫瘍内科学講座 主任教授／附属病院 腫瘍内科 部長・臨床腫瘍センター センター長／放射線医学県民健康管理センター がん登録室 室長）1992年岐阜大学医学部卒業後、東京都立駒込病院 外科、岐阜大学大学院医学研究科 生化学・外科、埼玉県立がんセンター研究所、カロリンスカ医科大学（スウェーデン）、東京都立駒込病院 乳腺外科・臨床試験科、M.D.アンダーソンがんセンター（米国・短期留学）、埼玉医科大学国際医療センター 腫瘍内科、京都大学大学院医学研究科 標的治療腫瘍学講座を経て2014年より現職。
主な研究分野は、ホルモン依存性乳がんの基礎生物学、内分泌療法と免疫療法に関する臨床研究。この分野でいくつかの研究プロジェクトを実施し、多数の論文を発表している。複数の国際共同第III相試験の運営委員であり、JCOGやJBCRGなどの大規模臨床研究グループの運営に携わり、JBCS（日本乳癌学会）、JSMO（日本腫瘍学会）、BIG（Breast International Group）の常任理事を務める。

>> 詳細はこちら

(Webinar) The 128th HGPI Seminar “Viewing Healthcare Disparities Through the Lens of Breast Cancer Treatment” (October 29, 2024)

October is Pink Ribbon Month, which is the month for raising breast cancer awareness. During this period, many events and activities aiming to raise awareness for breast cancer prevention are held in Japan and around the world. As part of these activities, Health and Global Policy Institute (HGPI) will host an HGPI Seminar to deepen understanding of disparities in healthcare by viewing various aspects of disparity through the lens of breast cancer treatment. The seminar will feature a lecture on the current state of breast cancer treatment and the ideal healthcare provision system from Dr. Shigehira Saji, Professor and Chairman of the Department of Medical Oncology at the Fukushima Medical University School of Medicine. From the perspective of breast cancer treatment, we will try to unravel the topic of disparity, which is recognized as an issue across the medical community.

■Speaker's Profile

Dr. Shigehira Saji (MD, PhD. Professor and Chairman, Department of Medical Oncology, Fukushima Medical University, School of Medicine)
Dr. Shigehira Saji is currently Professor and Chairman of the Department of Medical Oncology, Fukushima Medical University, School of Medicine. He also has an appointment as Director of Medical Oncology and Clinical Oncology Center of Fukushima Medical University Hospital.
He received MD degree in 1992 and PhD degree in 1999 from his hometown university, Gifu University School of Medicine. After residency at Tokyo Metropolitan Komagome Hospital, he accumulated his basic and clinical research experience at Saitama Cancer Center Research Institute (1998), Karolinska Institute, Sweden (1999-2001) and M.D. Anderson Cancer Center, Texas (2003).
Prior to his current appointment, he was chief physician of Tokyo Metropolitan Komagome Hospital (2001-2009), associate professor of Saitama Medical University (2009-2011) and of Kyoto University Graduate School of Medicine (2011-2014).
His main areas of research include basic biology of hormone dependent breast cancer and translational/clinical research related to endocrine therapy and immune therapy. He conducted several research projects and published numerous papers in this field. He is a steering committee member of several global phase-III studies. He is involved in running of large clinical study groups such as JCOG (Japan Clinical Oncology Group) and JBCRG (Japan Breast Cancer Research Group), and serves as executive board member of JBCS (Japanese Breast Cancer Society), JSMO (Japanese Society of Medical Oncology) and BIG (Breast International Group). He is also a Steering Committee member of EBCTCG (Early Breast Cancer Trialists’ Collaborative Group). He enjoys several tough sports such as ultramarathon around 70-120km, climbing the Japan Alps and backcountry skiing.

>> For more information, click here